Literature DB >> 10533549

Review of community prevalence of depression in later life.

A T Beekman1, J R Copeland, M J Prince.   

Abstract

BACKGROUND: Despite considerable interest, there is no consensus regarding the prevalence of depression in later life. AIMS: To assess the prevalence of late-life depression in the community.
METHOD: A systematic review of community-based studies of the prevalence of depression in later life (55+). Literature was analysed by level of caseness at which depression was defined and measured.
RESULTS: Thirty-four studies eligible for inclusion were found. The reported prevalence rates vary enormously (0.4-35%). Arranged according to level of caseness, major depression is relatively rare among the elderly (weighted average prevalence 1.8%), minor depression is more common (weighted average prevalence 9.8%), while all depressive syndromes deemed clinically relevant yield an average prevalence of 13.5%. There is consistent evidence for higher prevalence rates for women and among older people living under adverse socio-economic circumstances.
CONCLUSIONS: Depression is common in later life. Methodological differences between studies preclude firm conclusions about cross-cultural and geographical variation. Improving the comparability of epidemiological research constitutes an important step forward.

Entities:  

Mesh:

Year:  1999        PMID: 10533549     DOI: 10.1192/bjp.174.4.307

Source DB:  PubMed          Journal:  Br J Psychiatry        ISSN: 0007-1250            Impact factor:   9.319


  204 in total

1.  A neuropathological study of vascular factors in late-life depression.

Authors:  A J Thomas; I N Ferrier; R N Kalaria; R H Perry; A Brown; J T O'Brien
Journal:  J Neurol Neurosurg Psychiatry       Date:  2001-01       Impact factor: 10.154

2.  Why visually impaired older adults often do not receive mental health services: the patient's perspective.

Authors:  Hilde P A van der Aa; Mirke Hoeben; Linda Rainey; Ger H M B van Rens; Hilde L Vreeken; Ruth M A van Nispen
Journal:  Qual Life Res       Date:  2014-11-15       Impact factor: 4.147

3.  Depression among older people in Europe: the EURODEP studies.

Authors:  John R M Copeland; Aartjan T F Beekman; Arjan W Braam; Michael E Dewey; Philippe Delespaul; Rebecca Fuhrer; Christopher Hooijer; Brian A Lawlor; Sirkka-Liisa Kivela; Anthony Lobo; Halgrimur Magnusson; Anthony H Mann; Ingeborg Meller; Martin J Prince; Friedel Reischies; Marc Roelands; Ingmar Skoog; Cesare Turrina; Marten W deVries; Kenneth C M Wilson
Journal:  World Psychiatry       Date:  2004-02       Impact factor: 49.548

4.  Treating depression in later life.

Authors:  Carolyn Chew-Graham; Robert Baldwin; Alistair Burns
Journal:  BMJ       Date:  2004-07-24

5.  Parkinson disease: Depression and anxiety in Parkinson disease.

Authors:  Pablo Martínez-Martín; Javier Damián
Journal:  Nat Rev Neurol       Date:  2010-05       Impact factor: 42.937

Review 6.  Potential mechanisms underlying anxiety and depression in Parkinson's disease: consequences of l-DOPA treatment.

Authors:  Karen L Eskow Jaunarajs; Mariana Angoa-Perez; Donald M Kuhn; Christopher Bishop
Journal:  Neurosci Biobehav Rev       Date:  2010-07-06       Impact factor: 8.989

7.  Antidepressant Use in the Elderly Is Associated With an Increased Risk of Dementia.

Authors:  Chenkun Wang; Sujuan Gao; Hugh C Hendrie; Joe Kesterson; Noll L Campbell; Anantha Shekhar; Christopher M Callahan
Journal:  Alzheimer Dis Assoc Disord       Date:  2016 Apr-Jun       Impact factor: 2.703

Review 8.  Biological risk factors for late life depression.

Authors:  Henning Tiemeier
Journal:  Eur J Epidemiol       Date:  2003       Impact factor: 8.082

9.  Gene-behavior interaction of depressive symptoms and the apolipoprotein E {varepsilon}4 allele on cognitive decline.

Authors:  Kumar B Rajan; Robert S Wilson; Kimberly A Skarupski; Carlos F Mendes de Leon; Denis A Evans
Journal:  Psychosom Med       Date:  2014-01-16       Impact factor: 4.312

10.  Depression in the elderly: clinical features and risk factors.

Authors:  Gülfizar Sözeri-Varma
Journal:  Aging Dis       Date:  2012-10-21       Impact factor: 6.745

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.